ImmunoPrecise Antibodies Ltd. revenue breakdown overview

ImmunoPrecise Antibodies Ltd. revenue for the last year amounted to 15.27 M USD, the most of which — 14.05 M USD — came from its highest performing source at the moment, Antibody Production Project, the year earlier bringing 13.83 M USD. The greatest contribution to the revenue figure was made by Europe — last year it brought ImmunoPrecise Antibodies Ltd. 7.11 M USD, and the year before that — 7.51 M USD.